Literature DB >> 35522710

Toward a precision medicine approach for autoimmunity.

Stephan Kissler1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35522710      PMCID： PMC9171808          DOI： 10.1073/pnas.2204841119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  8 in total

Review 1.  DNA vaccines for the treatment of autoimmune disease.

Authors:  I A Ramshaw; S A Fordham; C C Bernard; D Maguire; W B Cowden; D O Willenborg
Journal:  Immunol Cell Biol       Date:  1997-08       Impact factor: 5.126

2.  The transfer of immunological competence to rats tolerant of sheep erythrocytes with lymphocytes from normal rats.

Authors:  P J McCullagh
Journal:  Aust J Exp Biol Med Sci       Date:  1970-08

3.  Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis.

Authors:  Jeremy Chataway; Keith Martin; Kevin Barrell; Basil Sharrack; Pelle Stolt; David C Wraith
Journal:  Neurology       Date:  2018-02-21       Impact factor: 9.910

4.  Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice.

Authors:  A Bot; D Smith; S Bot; A Hughes; T Wolfe; L Wang; C Woods; M von Herrath
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

5.  DNA immunization to prevent autoimmune diabetes.

Authors:  B Coon; L L An; J L Whitton; M G von Herrath
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

6.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.

Authors:  Jorge Postigo-Fernandez; Rebuma Firdessa-Fite; Rémi J Creusot
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

Review 8.  Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.

Authors:  Emma L Smith; Mark Peakman
Journal:  Front Immunol       Date:  2018-02-28       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.